232 related articles for article (PubMed ID: 23508898)
1. Antagonist binding and induced conformational dynamics of GPCR A2A adenosine receptor.
Pang X; Yang M; Han K
Proteins; 2013 Aug; 81(8):1399-410. PubMed ID: 23508898
[TBL] [Abstract][Full Text] [Related]
2. Communication over the network of binary switches regulates the activation of A2A adenosine receptor.
Lee Y; Choi S; Hyeon C
PLoS Comput Biol; 2015 Feb; 11(2):e1004044. PubMed ID: 25664580
[TBL] [Abstract][Full Text] [Related]
3. An insight into antagonist binding and induced conformational dynamics of class B GPCR corticotropin-releasing factor receptor 1.
Xu J; Wang Z; Liu P; Li D; Lin J
Mol Biosyst; 2015 Jul; 11(7):2042-50. PubMed ID: 25980590
[TBL] [Abstract][Full Text] [Related]
4. Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists.
Bacilieri M; Ciancetta A; Paoletta S; Federico S; Cosconati S; Cacciari B; Taliani S; Da Settimo F; Novellino E; Klotz KN; Spalluto G; Moro S
J Chem Inf Model; 2013 Jul; 53(7):1620-37. PubMed ID: 23705857
[TBL] [Abstract][Full Text] [Related]
5. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor.
Guo D; Pan AC; Dror RO; Mocking T; Liu R; Heitman LH; Shaw DE; IJzerman AP
Mol Pharmacol; 2016 May; 89(5):485-91. PubMed ID: 26873858
[TBL] [Abstract][Full Text] [Related]
6. Binding kinetics of ZM241385 derivatives at the human adenosine A2A receptor.
Guo D; Xia L; van Veldhoven JP; Hazeu M; Mocking T; Brussee J; Ijzerman AP; Heitman LH
ChemMedChem; 2014 Apr; 9(4):752-61. PubMed ID: 24591302
[TBL] [Abstract][Full Text] [Related]
7. Crystallogenesis of adenosine A(2A) receptor-T4 lysozyme fusion protein: a practical route for the structure.
Ashok Y; Nanekar RT; Jaakola VP
Methods Enzymol; 2013; 520():175-98. PubMed ID: 23332700
[TBL] [Abstract][Full Text] [Related]
8. Suppression of bladder overactivity by adenosine A2A receptor antagonist in a rat model of Parkinson disease.
Kitta T; Chancellor MB; de Groat WC; Kuno S; Nonomura K; Yoshimura N
J Urol; 2012 May; 187(5):1890-7. PubMed ID: 22425056
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors.
Rodríguez D; Piñeiro Á; Gutiérrez-de-Terán H
Biochemistry; 2011 May; 50(19):4194-208. PubMed ID: 21480628
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the adenosine A
Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
[TBL] [Abstract][Full Text] [Related]
11. GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A
Shiriaeva A; Park D; Kim G; Lee Y; Hou X; Jarhad DB; Kim G; Yu J; Hyun YE; Kim W; Gao ZG; Jacobson KA; Han GW; Stevens RC; Jeong LS; Choi S; Cherezov V
J Med Chem; 2022 Sep; 65(17):11648-11657. PubMed ID: 35977382
[TBL] [Abstract][Full Text] [Related]
12. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
Rodríguez D; Gao ZG; Moss SM; Jacobson KA; Carlsson J
J Chem Inf Model; 2015 Mar; 55(3):550-63. PubMed ID: 25625646
[TBL] [Abstract][Full Text] [Related]
13. Deciphering conformational selectivity in the A2A adenosine G protein-coupled receptor by free energy simulations.
Jespers W; Heitman LH; IJzerman AP; Sotelo E; van Westen GJP; Åqvist J; Gutiérrez-de-Terán H
PLoS Comput Biol; 2021 Nov; 17(11):e1009152. PubMed ID: 34818333
[TBL] [Abstract][Full Text] [Related]
14. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
Zeng L; Guan M; Jin H; Liu Z; Zhang L
Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
[TBL] [Abstract][Full Text] [Related]
15. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
Lebon G; Warne T; Edwards PC; Bennett K; Langmead CJ; Leslie AG; Tate CG
Nature; 2011 May; 474(7352):521-5. PubMed ID: 21593763
[TBL] [Abstract][Full Text] [Related]
16. Allosteric Antagonism of the A
Gao ZG; Toti KS; Campbell R; Suresh RR; Yang H; Jacobson KA
Cells; 2020 May; 9(5):. PubMed ID: 32408534
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
18. A
De Filippo E; Hinz S; Pellizzari V; Deganutti G; El-Tayeb A; Navarro G; Franco R; Moro S; Schiedel AC; Müller CE
Biochem Pharmacol; 2020 Feb; 172():113718. PubMed ID: 31751537
[TBL] [Abstract][Full Text] [Related]
19. Kinetic and functional properties of [3H]ZM241385, a high affinity antagonist for adenosine A2A receptors.
Uustare A; Vonk A; Terasmaa A; Fuxe K; Rinken A
Life Sci; 2005 Feb; 76(13):1513-26. PubMed ID: 15680315
[TBL] [Abstract][Full Text] [Related]
20. Potential role of A2A adenosine receptor in traumatic optic neuropathy.
Ahmad S; Fatteh N; El-Sherbiny NM; Naime M; Ibrahim AS; El-Sherbini AM; El-Shafey SA; Khan S; Fulzele S; Gonzales J; Liou GI
J Neuroimmunol; 2013 Nov; 264(1-2):54-64. PubMed ID: 24090652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
